Supplementation of EAAs reduces p-GCN2 and partially rescued the growth deficiency of GCN2 KO cells, suggesting that deficiency of at least some of these critical amino acids are limiting in proliferating PCa cells. The gene discussed is EIF2AK4; the disease is posterior cortical atrophy.